News Focus
News Focus
icon url

DewDiligence

01/13/17 5:06 PM

#207979 RE: north40000 #207178

DXCM +26% on new CMS classification for G5 continuous glucose monitor:

http://finance.yahoo.com/news/centers-medicare-medicaid-services-cms-023000591.html

It's notable that the FDA label expansion for the G5 monitor three weeks ago did nothing for the stock price (#msg-127319780), but the new CMS classification—which is what drives reimbursement—caused a big move.